FINWIRES · TerminalLIVE
FINWIRES

Lupin, Natco Win USFDA Nod for Generic Cancer Drug Eribulin Mesylate

By

Lupin (NSE:LUPIN, BOM:500257) and its alliance partner Natco Pharma (NSE:NATCOPHARM, BOM:524816) said the US Food and Drug Administration has approved Eribulin Mesylate injection, 1 mg/2 mL, according to a filing.

The drug is a generic version of Eisai Inc.'s reference drug Halaven, the filing said. It is used for the treatment of metastatic breast cancer in patients who have received prior chemotherapy and for unresectable or metastatic liposarcoma.

Halaven recorded estimated annual US sales of $43.7 million, based on IQVIA MAT April 2026 data, it added.

Shares of Natco Pharma fell over 1% in Wednesday's trade.

Related Articles

Asia

Guizhou Chanhen Chemical Subsidiary to Slash Capital After Partner Withdraws

Guizhou Chanhen Chemical (SHE:002895) controlled subsidiary Hengxuan New Energy will reduce registered capital by 160 million yuan after minority shareholder Guoxuan Holding ceased its unpaid capital contribution obligation.The reduction will lower Hengxuan New Energy's registered capital to 640 million yuan from 800 million yuan.Guizhou Chanhen Chemical's contribution remains unchanged at 480 million yuan, but its stake rose to 75% from 60%, while Guoxuan Holding's stake declined to 25% from 40%.

$SHE:002895
Asia

Market Chatter: Tata Motors to Use Chery's Automaking Platform in Premium EVs

Tata Motors (BOM:500570, NSE:TATAMOTORS) plans to license Chery Automobile's (HKG:9973) Freelander, an automaking platform developed in a joint venture between the Chinese firm and Jaguar Land Rover, Reuters reported Wednesday, citing people familiar with the matter.The Indian automaker plans to incorporate the platform in its electric vehicles under its premium Avinya brand, which will be manufactured at the newly opened factory in Tamil Nadu, according to the report.The first model under the Avinya brand is scheduled to launch in 2027, the report said.Shares of Tata Motors rose nearly 1% in recent trade, while those of Chery Automobile declined nearly 3% at market close.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$BOM:500570$HKG:9973$NSE:TATAMOTORS
Asia

S&P Gives Danantara Investment Management BBB Long-Term and A-2 Short-Term Credit Ratings

S&P Global Ratings assigned BBB long-term and A-2 short-term issuer credit ratings to Danantara Investment Management, according to a Wednesday release.The outlook is stable, reflecting that on the rating agency's sovereign credit rating on Indonesia, the release said.The ratings reflect S&P Global's almost certain likelihood of sufficient extraordinary support from the Indonesian government for the firm in times of need.

$^JKSE